Category: Finance | Title: Veterinary Industry Facts, Revenue, and Key Players | Tag: Veterinary Finance | Meta Description: Concise facts and figures on the veterinary industry, including revenue, employment, and major companies...
Industry Size and Revenue
The global veterinary services market reached an estimated 35 billion dollars in 2024, with companion animal care driving the majority of growth. The United States remains the largest national market, accounting for roughly 16 billion dollars in annual revenue. According to market analysts, the sector has expanded at a compound annual growth rate of about 7 percent over the past five years. The industry includes private practices, corporate hospital chains, diagnostics firms, and pharmaceutical suppliers. Key revenue streams include preventive care, surgery, dental procedures, and specialty internal medicine.
Corporate consolidation has accelerated as private equity firms and publicly traded companies acquire independent practices. Mars Veterinary Health, a division of Mars Inc., operates more than 2,500 hospitals worldwide under brands such as Banfield and VCA. Antech Diagnostics, majority owned by a private equity consortium, processes millions of laboratory tests annually for veterinary clinics. These companies leverage scale to negotiate lower pricing on pharmaceuticals and medical devices. The trend toward corporate ownership has reshaped practice economics and employment models across North America and Europe.
Employment and Workforce
The U.S. Bureau of Labor Statistics reports that employment for veterinarians is projected to grow 20 percent from 2022 to 2032, much faster than the average for all occupations. As of 2024, there are approximately 100,000 licensed veterinarians practicing in the United States. The veterinary technician workforce exceeds 120,000 and supports clinical operations in hospitals and research facilities. Median annual wages for veterinarians exceeded 100,000 dollars in recent surveys, while vet techs earn a median wage near 40,000 dollars. Shortages in rural and underserved areas continue to create recruitment challenges for corporate chains and nonprofit organizations.
Veterinary school graduates carry significant educational debt, with the average indebtedness exceeding 150,000 dollars in 2024. The American Veterinary Medical Association tracks workforce supply and demand to advise policymakers and academic institutions. Several new veterinary schools have opened in the past decade to address regional shortages. Corporate hospital groups invest in training programs and continuing education to reduce turnover. Workforce data from the AVMA and the U.S. Department of Labor inform hiring strategies at major practice networks.
Regulation and Market Structure
Veterinary pharmaceuticals and biologics are regulated by the U.S. Food and Drug Administration's Center for Veterinary Medicine. The FDA maintains the Green Book, which lists approved animal drugs and their sponsors. Companies such as Elanco Animal Health and Zoetis rank among the largest veterinary pharmaceutical firms globally. These firms invest heavily in research and development for antibiotics, parasiticides, and vaccines. Regulatory compliance affects product labeling, manufacturing standards, and marketing claims for companion and food-producing animals.
The Securities and Exchange Commission requires public veterinary companies to disclose financial results, risk factors, and governance practices. Mars Inc., while privately held, is widely cited in industry reports as the dominant corporate player in veterinary services. Publicly traded Zoetis and Elanco file quarterly earnings reports that provide detailed revenue breakdowns by product line and geography. Investors use these filings to assess exposure to pet care spending cycles and pharmaceutical pipelines. Market concentration continues to rise as private equity-backed acquisitions consolidate independent practices into larger groups.